Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 28 recruiting now early-phase tilt

Depressive Symptoms: early-phase trial registry

28 of 61 indexed Depressive Symptoms trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #232 of 28,707 conditions by registered trial count.

61 US clinical trials · 28 currently recruiting · #232 of 28,707 conditions by registered trial count

Depressive Symptoms: 61 US clinical trials tracked, 28 recruiting.

Depressive Symptoms is the subject of 61 registered US clinical trials on ClinicalTrials.gov, 28 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is Johns Hopkins University, running 3 of these trials.

Enrollment posture brief

Registry condition depressive-symptoms

OPEN 28 | RECR 46% | LATE 1 | EARLY 5 | RANK #232 | SPON 3

Nearest open-share peer: Breastfeeding (46% recruiting · 37 trials)

Cholangiocarcinoma59%Cognitive Decline58.1%Depressive Symptoms (this)46%Malignant Neoplasm34.4%HIV/AIDS24.2%
Open-enrollment share among volume-matched conditions near Depressive Symptoms

Depressive Symptoms lists 28 open slots (46% of 61 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Depressive Symptoms on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Depressive Symptoms is recruiting above its size-band peers.

    28 of 61 indexed trials (45.9%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Depressive Symptoms trials is spread across many organizations.

    Johns Hopkins University accounts for 3 of 61 trials (4.9%). 49 distinct sponsors appear on at least one study for this condition label.

  3. Typical Depressive Symptoms enrolment sits around 96 participants.

    Median target enrolment is 96 among the 61 trials that report a genuine target (sentinel values excluded). 31 of those (50.8%) plan for fewer than 100 participants.

  4. Depressive Symptoms research is mostly interventional.

    59 interventional and 2 observational studies make up this index (96.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 24Phase 41

Open and recent trials

61 total, page 2 of 2

COMPLETED NA 68 participants

Testing a Positive Psychology-based Intervention for Couples Coping With Stroke

University of Utah

NCT03335358

COMPLETED NA 68 participants

Stepped-Care Telehealth for Distress in Cancer Survivors

Wake Forest University Health Sciences

NCT03060096

COMPLETED NA 54 participants

Accelerated Resolution Therapy for Complicated Grief

University of South Florida

NCT03484338

COMPLETED NA 53 participants

Examine the Effects of Meditation on Daily Psychological Stress Responses in Woman With a History of Child Adversity

University of California, San Francisco

NCT04606199

COMPLETED NA 52 participants

Stress-reduction Wellness Program for Midlife Black Women (B-SWELL)

University of Cincinnati

NCT04404478

COMPLETED NA 50 participants

Vitamin D for Improving Metabolic Control and Depressive Symptoms

Loyola University

NCT01185574

COMPLETED NA 42 participants

Attachment and Biobehavioral Catch-up for Depression

University of California, San Francisco

NCT04050202

COMPLETED Phase 2 29 participants

Beating the Blues for Your Heart

Indiana University

NCT01605552

COMPLETED NA 19 participants

Internet-Based Cognitive Behavioral Therapy for Depressive Symptoms in Adolescents With Type 1 Diabetes Mellitus

University of Texas Southwestern Medical Center

NCT03655067

COMPLETED NA 9 participants

Can Rumination-Focused Cognitive Behavioral Therapy Reduce the Risk of Cardio-vascular Disease?

University of Louisville

NCT05980130

COMPLETED NA 3 participants

Programs to Support You During Chemotherapy (Pro-You)

Vanderbilt-Ingram Cancer Center

NCT02148406

← Previous Page 2 of 2

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 4
Phase 4 1

Named interventions

Most-linked intervention names on Depressive Symptoms records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

EMSELLA (HPM-6000UF) Sham Treatment Device
2 trials
EXOMIND (BTL-699-2) Sham Treatment Device
2 trials
EMSELLA (HPM-6000UF) ActiveTreatment Device
2 trials
Project UPLIFT Behavioral
2 trials
Enhanced Usual Care Control Other
1 trials
Moderate Anxiety/depression: Low Intensity Stepped care Other
1 trials
Severe Anxiety/depression: High Intensity Stepped Care Other
1 trials
Dyadic (couples-based) positive psychology intervention Behavioral
1 trials

US sites by state

Facility locations filed on Depressive Symptoms trials. A trial with sites in several states counts in each.

California 9 trials
New York 7 trials
Texas 6 trials
Ohio 5 trials
Michigan 5 trials
Maryland 5 trials
Illinois 5 trials
Pennsylvania 4 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Depressive Symptoms page

61 registered trials, 28 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Depressive Symptoms condition card totals 61 registered trials; most-linked intervention EMSELLA (HPM-6000UF) Sham Treatment; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.